Mucormycosis Clinical Trial
Official title:
Diagnostic Marker of Mucormycosis : Development and Evaluation of a Diagnostic Assay on a Cohort of Sera
Mucormycosis (MM) is one of the main invasive fungal infection (IFI), and is determined by filamentous fungi belonging to the order of Mucorales, with a mortality rate ranging from 20 to 60% according to localization. Prompt initiation of adequate antifungal therapy is critical for treating mucormycosis. Early diagnostic is therefore essential. The presence in the Mucorales' cell wall of uncommon monosaccharides open interesting perspectives for the development of specific diagnostic biomarkers. This study evaluate a diagnostic test for mucormycosis in a cohort of patients with MM and in control groups (high-risk patients without MM and patients with another IFI).
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03387696 -
Mucormycosis in ICU
|
||
| Recruiting |
NCT04744454 -
Post Marketing Surveillance (PMS) Study of Cresemba in Korea.
|
||
| Completed |
NCT00419770 -
The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study
|
Phase 2 | |
| Recruiting |
NCT05925660 -
Mucorales PCR Screening in At-risk Hematology Patients
|
N/A | |
| Completed |
NCT04935463 -
Mucormycosis in COVID-19
|
||
| Completed |
NCT04550936 -
Patterns of Real-World Isavuconazole Use - a Study of Patients With Mucormycosis or Invasive Aspergillosis
|
||
| Completed |
NCT05074043 -
COVID-19 Associated Mucormycosis: A Multidisciplinary Dilemma in Assiut University Hospital
|
||
| Completed |
NCT02845934 -
Prospective Evaluation of a New Molecular Tool for Early Diagnosis of Mucormycosis
|
N/A | |
| Completed |
NCT05348434 -
Evaluation of Using 3D Printed PEEK Facial Implants in Repairing Maxillofacial Deformities
|
||
| Completed |
NCT05212961 -
COVID-19 and Rhino-orbital Mucormycosis
|
||
| Recruiting |
NCT05097664 -
Ocular Manifestation and Related Risk Factors of Covid-19 Associated Mucormycosis: a Multicenter Study in Iran
|